Sheela Upadhyaya | Life Science Advisor in Rare Diseases
Openflex Ltd
Appearances:
Day 2 - Wednesday 29 October @ 12:00
Panel: Implications of EU HTA Joint Clinical Assessments to Patient Engagement Practices in Rare Diseases
This panel will explore the practical implications that industry and patient organizations need to consider when engaging given the evolving landscape of HTA in Europe
last published: 18/Sep/25 10:55 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events